Financial Snapshot

Revenue
$235.2K
TTM
Gross Margin
13.05%
TTM
Net Earnings
-$4.970M
TTM
Current Assets
Q3 2023
Current Liabilities
Q3 2023
Current Ratio
0.23%
Q3 2023
Total Assets
Q3 2023
Total Liabilities
Q3 2023
Book Value
-$5.249M
Q3 2023
Cash
Q3 2023
P/E
-0.01607
Sep 13, 2024 EST
Free Cash Flow
-$1.364M
TTM

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

Selling, General & Admin Expense

Research & Development

No data

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

No data

DDA To Gross Profit Ratio

No data

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

Interest Expenses

Interest Expenses To Operating Income %

No data

Other Expense/Income

Interest & Other Expense/Income

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

No data

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

No data

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

No data

Assets & Liabilities

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $79.878 Thousand

About MediXall Group, Inc.

MediXall Group, Inc. is a technology company, which engages in the development of a healthcare marketplace platform. The company is headquartered in Fort Lauderdale, Florida and currently employs 17 full-time employees. The company went IPO on 2003-01-16. The firm is engaged in delivering products and services to help consumers learn, decide, and pay for healthcare in ways that complement relationships with trusted doctors. With Health Karma, it has created a membership model that provides consumers with convenience and access to whenever and wherever, while driving down overall healthcare costs. The company provides its members access to licensed healthcare providers across a spectrum of care through copay virtual primary, urgent, and behavioral care, as well as significant discounts to prescriptions, dental care, eye care, hearing and medical equipment. For employers, Its Health Karma membership offers a comprehensive way for them to offer supplemental health benefits to all of their employees, including part-time and gig workers. The Company’s subsidiaries include Medixaid, Inc., MediXall.com, Inc. and Health Karma, Inc.

Industry: Railroads, Line-Haul Operating Peers: Augmedix, Inc. Better Therapeutics, Inc. BIOTRICITY INC. HealthLynked Corp ICAD INC STREAMLINE HEALTH SOLUTIONS INC. MobileSmith, Inc. NantHealth, Inc.